Ann‐Charlotte Egnell
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 5
-
- Computational Drug Discovery Methods 2
-
- Drug Transport and Resistance Mechanisms 2
-
- Adenosine and Purinergic Signaling 2
-
- Pharmacological Effects and Toxicity Studies 2
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 1
-
- Diabetic Foot Ulcer Assessment and Management 1
-
- Analytical Chemistry and Chromatography 1
- Co-authors
- Brian HoustonScott BoyerJulia A. HaslerTashinga E. BapiroCollen MasimirembwaJohn L. JoyalCecilia ArfvidssonRegina Fritsche‐Danielson
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Ann‐Charlotte Egnell
11 papers receiving 452 citations
Peers
Comparison fields: 5 of 88
- Pharmacology 182
- Computational Theory and Mathematics 87
- Oncology 96
- Molecular Biology 218
- Biochemistry 21
Countries citing papers authored by Ann‐Charlotte Egnell
This map shows the geographic impact of Ann‐Charlotte Egnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Charlotte Egnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Charlotte Egnell more than expected).
Fields of papers citing papers by Ann‐Charlotte Egnell
This network shows the impact of papers produced by Ann‐Charlotte Egnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Charlotte Egnell. The network helps show where Ann‐Charlotte Egnell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ann‐Charlotte Egnell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2022 | 1 | |
| 4 | 2019 | 152 | |
| 5 | 2015 | 21 | |
| 6 | 2013 | 46 | |
| 7 | 2005 | 28 | |
| 8 | 2003 | 42 | |
| 9 | 2003 | 54 | |
| 10 | Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. | 2001 | 85 |
| 11 | 2001 | 41 |
About Ann‐Charlotte Egnell
Ann‐Charlotte Egnell is a scholar working on Pharmacology, Physiology and Genetics, having authored 11 papers that have together received 474 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Adenosine and Purinergic Signaling (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Computational Drug Discovery Methods (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Diabetic Foot Ulcer Assessment and Management (1 paper) and Analytical Chemistry and Chromatography (1 paper). The work is most often cited by research in Pharmacology (182 citations), Computational Theory and Mathematics (87 citations) and Oncology (96 citations). Ann‐Charlotte Egnell has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Brian Houston, Scott Boyer, Julia A. Hasler, Tashinga E. Bapiro, Collen Masimirembwa, John L. Joyal, Cecilia Arfvidsson, Regina Fritsche‐Danielson, Rainard Fuhr and Ligia Chialda. Their work appears in journals such as Circulation, Nature Communications and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.